Black Triangle medicines — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — The medicine is subject to intensive monitoring and all suspected adverse reactions should be reported, even if they are well-known or minor
The Black Triangle symbol indicates that a medicine is subject to additional monitoring, usually because it is relatively new or there is limited long-term safety data. Healthcare professionals are asked to report all suspected adverse reactions to Black Triangle medicines through the Yellow Card scheme, not just serious or unexpected ones. This intensive monitoring helps the MHRA build a comprehensive safety profile. The medicine has not been withdrawn and does not have special legal requirements.
Reference: BNF; MHRA